Articles

As the holiday season approaches, regulators and law enforcement continue to remind companies that cyber events are on the rise. Holidays and weekends, when offices are closed and employees are on break, can make businesses more susceptible to cyber attacks, including ransomware, phishing scams, data theft, DDoS attacks, and more.…

Gooder Foods, Inc., a KO client, recently raised $6.4 million to launch Goodles – a new, healthier mac and cheese brand. The KO team, led by partner Jennifer Rosenthal, represented Gooder Foods. Co-founded by actress Gal Gadot, Goodles is high in vegetables, protein and fiber and aims to provide a tastier,…

Superplastic, a KO client and global entertainment brand, has raised $20 million to expand its first-of-its-kind virtual ecosystem. The KO team, led by partner Jon Taylor, represented Superplastic.   Superplastic creates and manages animated celebrities with millions of dedicated followers, including Janky & Guggimon, Dayzee & Staxx, Kranky, ShüDog and more. Via its ecosystem,…

Hope Foods LLC, a leading brand of hummus and other plant-based dips, has been acquired French dairy firm SAVENCIA Fromage & Dairy. The KO team, led by attorney Ian Kuliasha and partner Jennifer Rosenthal, represented Hope Foods in the acquisition. The acquisition includes Hope Foods’ manufacturing plant in Louisville, Colo.…

KO Client Plato BioPharma, Inc., a Colorado-based pharmacology research and drug discovery company, has been acquired by leading contract research organization Inotiv, Inc. The KO team, led by partner John Gaddis, represented Plato BioPharma in the acquisition. Plato BioPharma specializes in cardiovascular, renal, pulmonary and hepatic therapeutic areas, specifically within…

KO Law Firm is growing again. In recent months, the firm has expanded our practice with the addition of new attorneys Logan DeSouza, Robert Donald, Charu Ganesh, Ryan Ivey and Kyle Pawlak. Not only are these additions high-caliber attorneys with a breadth of experience — they also bring unique, diverse experiences…

Sydnexis, Inc., a clinical stage biopharmaceutical company, has completed a $45 million Series B financing led by Visionary Ventures, Blue Stem Capital, and SC Master Fund. The KO team, led by partners Kevin Gibson and Brad Schoenfeld, represented Sydnexis. The company sees progressive myopia (nearsightedness) in children as a “significant…

Merger and acquisition (M&A) deal volume hit an all-time high in the first six months of 2021. Fueled by economic growth, low capital costs and the reopening of society in many places, this trend shows no sign of slowing down before year end. Consider this: according to Refinitiv, one of…